Portable Oxygen Concentrator (OX-1A-E, OX-1B)
Oxytek Medical Technology Co., Ltd. · Decision date Sep 23, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-09-23 for K254289, a traditional 510(k) submitted by Oxytek Medical Technology Co., Ltd. of Foshan, China, for the Portable Oxygen Concentrator models OX-1A-E and OX-1B. The device falls under classification name Generator, Oxygen, Portable, regulation number 868.5440, product code CAW, with anesthesiology as the regulation medical specialty and review panel. The application was received on 12/31/2025.
SESE means the submission was cleared as substantially equivalent; it is not a PMA approval. The record lists Share Info (Guangzhou) Medical Consultant, Ltd. as correspondent, a traditional submission type, no third-party review, no combination product status, and no authorized predetermined change control plan. The public record does not include the predicate device, the summary of technological characteristics, or any performance testing, so the basis for the equivalence finding and the specific differences between the two models remain unknown.
The page was last updated 10/19/2026. No clinical, labeling or postmarket conclusions are drawn here.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Anesthesiology
- Decision date
- Sep 23, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K254289
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Oxytek Medical Technology Co., Ltd.
- Product code
- CAW
- Decision code
- SESE
- Decision date
- Sep 23, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Generator, Oxygen, Portable.
- Applicant
- Oxytek Medical Technology Co., Ltd.
- Product code
- CAW
- FDA device class
- 2
FDA decision timeline
K254289 received
Application receipt date recorded by FDA.
K254289 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Oxytek Medical Technology Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Chencun Town, Shunde District, Foshan
Sources and methodology
- Original FDA record: K254289
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records